Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.570 USD | +1.08% | +10.98% | -33.37% |
09-03 | Jefferies Cuts Price Target on Recursion Pharmaceuticals to $6 From $8, Maintains Hold Rating | MT |
09-03 | Recursion Pharmaceuticals Says REC-994 Phase 2 Trial Shows Safety and Efficacy Trends | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Official Publications
MarketScreener is also available in this country: United States.
Switch edition